$1.270
+0.041 (+3.25%)Al cierre
Noticias de CNTY
Eventos de CNTY
Century Casinos Q2 Revenue at $152M, Below Consensus
Reports Q2 revenue $152M, consensus $153.86M. "We are very pleased with the results of our North American operations during the second quarter, driven by a strong performance at the Nugget, in the US West reportable segment, as well as in the US Midwest reportable segment, which includes our Missouri and Colorado properties. The Nugget's Adjusted EBITDAR grew an additional 93%, after growing by 93% in the first quarter, and we will continue to work diligently at the property to continue this performance throughout 2026 and beyond. Unfortunately, the results in North America were negatively impacted by Poland, which continued to underperform due, in part, to low table hold in June 2026. However, we are seeing some signs of improvement in Poland that should lead to better results over the next several quarters," Erwin Haitzmann and Peter Hoetzinger, Co-Chief Executive Officers of Century Casinos, remarked.
Century Casinos Files $100M Mixed Securities Shelf
Century Casinos files $100M mixed securities shelf
Century Casinos Reports Q1 Revenue of $137.24M
Reports Q1 revenue $137.24M, consensus $138.4M. "The first quarter of 2026 was an all-time record for net operating revenue in a first quarter in the Company's history, and we saw all North American properties outperform the first quarter of 2025 in both net operating revenue and Adjusted EBITDAR. The growth was driven by strong play from our high-value and core customer groups. We are particularly pleased with the results at the Nugget, which saw an increase to Adjusted EBITDAR of 93% compared to the first quarter of 2025," Erwin Haitzmann and Peter Hoetzinger, co-CEOs of Century Casinos, remarked.
Century Therapeutics Completes $135M Private Placement Financing
Century Therapeutics has entered into a securities purchase agreement for a private placement for initial gross proceeds of approximately $135M to the Company, before placement agent fees and offering expenses. The financing is being led by new investor TCGX, and includes participation from additional new and existing investors, including RA Capital Management, Commodore Capital, Deep Track Capital, RTW Investments, Venrock Healthcare Capital Partners, and the T1D Fund. The private placement is expected to close on January 9, subject to customary closing conditions. Pursuant to the terms of the securities purchase agreement, Century Therapeutics will issue approximately 117,391,299 shares of common stock and accompanying warrants to purchase 58,695,648 shares of common stock in the private placement at a purchase price of $1.15 per share and accompanying warrant to purchase 0.5 shares of common stock and at a purchase price of $1.1499 per pre-funded warrant and accompanying warrant to purchase 0.5 shares of common stock. The pre-funded warrants will be exercisable immediately at an exercise price of $0.0001 per share and will not expire until exercised in full. The warrants to purchase common stock will be exercisable immediately upon issuance at an exercise price of $2.60 per share or $2.599 per pre-funded warrant and will expire upon the earlier of 30 days after the public announcement of initial Phase 1 clinical data for CNTY-813 and the third anniversary of the closing of the private placement. Full exercise of the warrants would provide an additional approximately $153M in gross proceeds to the Company. Leerink Partners, TD Cowen and Mizuho acted as the placement agents for the private placement.
BetMGM Launches Sports Betting in Missouri with Century Casinos Partnership
BetMGM, made from a partnership between MGM Resorts (MGM) and Entain, announced the launch of mobile and retail sports betting in Missouri with its partner Century Casinos (CNTY). Players across the state can now place wagers through BetMGM's mobile app or in the new BetMGM Sportsbook at Century Casino & Hotel Cape Girardeau.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.